Key result
Increasing neutrophil count was independently associated with elevated cardiac troponin T levels during COPD exacerbations (OR 1.52 for a 5 × 10^6/ml increase).
Why the study?
What clinical and biochemical factors are associated with cardiac troponin T elevation in patients hospitalized for COPD exacerbation?
Cross-Sectional (n=441)
No
What clinical and biochemical factors are associated with cardiac troponin T elevation in patients hospitalized for COPD exacerbation?
Effect estimate: OR 1.52 (95% CI 1.20-1.94)
Cardiac troponin T elevation during COPD exacerbation is multifactorial, independently driven by systemic inflammation (neutrophils), renal impairment, tachycardia, anemia, and underlying ischemic heart disease.
Neutrophil count may flag cardiac risk during COPD exacerbation; observational data leaves causal role and interventions open.
BACKGROUND: Cardiac Troponin T (cTnT) elevation during exacerbations of chronic obstructive pulmonary disease (COPD) is associated with increased mortality the first year after hospital discharge. The factors associated with cTnT elevation in COPD are not known. METHODS: From our hospital's database, all patients admitted with COPD exacerbation in 2000-03 were identified. 441 had measurement of cTnT performed. Levels of cTnT > or = 0.04 microg/l were considered elevated. Clinical and historical data were retrieved from patient records, hospital and laboratory databases. Odds ratios for cTnT elevation were calculated using logistic regression. RESULTS: 120 patients (27%) had elevated cTnT levels. The covariates independently associated with elevated cTnT were increasing neutrophil count, creatinine concentration, heart rate and Cardiac Infarction Injury Score (CIIS), and decreasing hemoglobin concentration. The adjusted odds ratios (95% confidence intervals in parentheses) for cTnT elevation were 1.52 (1.20-1.94) for a 5 x 106/ml increase in neutrophils, 1.21 (1.12-1.32) for a 10 micromol/l increase in creatinine, 0.80 (0.69-0.92) for a 1 mg/dl increase in hemoglobin, 1.24 (1.09-1.42) for a 10 beats/minute increase in heart rate and 1.44 (1.15-1.82) for a 10 point increase in CIIS. CONCLUSION: Multiple factors are associated with cTnT elevation, probably reflecting the wide panorama of comorbid conditions typically seen in COPD. The positive association between neutrophils and cTnT elevation is compatible with the concept that an exaggerated inflammatory response in COPD exacerbation may predispose for myocardial injury.
No takes yet. Share an insight, caveat, or question.
Brekke et al. (2009) conducted a cross-sectional in COPD exacerbation (n=441). Clinical, biochemical and radiographic variables (e.g., neutrophil count) was evaluated on Elevated cTnT (≥ 0.04 μg/l) (OR 1.52, 95% CI 1.20-1.94). Increasing neutrophil count was independently associated with elevated cardiac troponin T levels during COPD exacerbations (OR 1.52 for a 5 × 10^6/ml increase).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: